Actively Recruiting
Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Led by University of Ulm · Updated on 2024-01-17
100
Participants Needed
1
Research Sites
643 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The present study focuses on patients with Pseudomonas aeruginosa (PSA) sepsis. The aim of the present study is to find out whether the M1 (pro-inflammatory) or M2 (anti-inflammatory) phenotype predominates in blood monocytes in critically ill patients with PSA-sepsis, and whether the severity of sepsis and outcome is associated with distinct monocyte phenotype and function.
CONDITIONS
Official Title
Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 18 years
- Critically ill patients with sepsis
- Microbiologically confirmed infection with Pseudomonas aeruginosa
You will not qualify if you...
- Life expectancy less than 24 hours
- Currently participating in other studies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinic of Anesthesiology
Ulm, Germany, 89070
Actively Recruiting
Research Team
M
Manfred Weiss, MD, MBA
CONTACT
E
Eberhard Barth, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here